Industry Insights with Crown Bioscience: In Vitro Technologies for Studying the Cancer-Immunity Cycle (Podcast)

Airdate: Friday, November 11, 2022 Season: 1 Episode: 11

Guests: Rajendra Kumari, Gera Goverse

In this special episode of Industry Insights, we spoke with Dr. Rajendra Kumari and Dr. Gera Goverse from Crown Bioscience. Jen and Gera provide an overview of the cancer-immunity cycle and describe in vivo, in vitro, and ex vivo research tools to study immuno-oncology. In particular, they compare the benefits and limitations of in vivo models, ex vivo patient-derived tissues, and 2D and 3D cell cultures, talk about how organoids and high content imaging are impacting the field, and discuss a recent shift towards more physiologically relevant in vitro assays.

To watch our recent webinar, Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle, click here.

To read out recent blog article, The Cancer-Immunity Cycle: Research Solutions for Preclinical Immuno-Oncology, click here.

Read the full blog and watch the interview here.

Associated Webinar: Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle

You can listen to this podcast on:

Similar Podcasts

#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8⁺ T Cell Co-culture Experiments

Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.

#ExpertAnswers: Lorcan Sherry and Aditya Pratapa on Analyzing Multiplex Immunofluorescence Images

Dr. Lorcan Sherry and Dr. Aditya Pratapa answer questions from a recent webinar where they present a novel workflow for analyzing multiplex immunofluorescence images.

#ExpertAnswers: Conor McCartin on Phage Display Technologies

Dr. Conor McCartin from ProteoGenix answers questions about the utilization of phage display in the development of human antibodies.

Related Content

Circulating Nucleosome Quantification (Nu.Q®) Technology for Monitoring Target Engagement and Adverse Events in Oncology Trials

Join us for a comprehensive webinar featuring experts in epigenetics and assay development, focusing on the scientific foundations and applications of Nucleosome Quantification (Nu.Q®) Technology in the realms of drug development and disease monitoring.

The Translational Utility of Ultrasound and Photoacoustics in Head and Neck Oncology

Dr. Mukund Seshadri presents his interdisciplinary research on developing and evaluating ultrasound and photoacoustic imaging for oral oncology applications, with a focus on the prognostic utility of these methods in assessing treatment responses in head and neck cancer patients.